Table 1.
Study Participant Characteristics at Enrollment (n = 200)
| Characteristic | n (%) |
|---|---|
| Age (years) | |
| <25 | 129 (64.5) |
| ≥25 | 71 (35.5) |
| Race/ethnicity | |
| Non–African American/ non-Hispanica | 13 (6.5) |
| African American/ non-Hispanic | 187 (93.5) |
| Chlamydia status | |
| Spontaneous resolution | 44 (22.0) |
| Persisting infection | 156 (78.0) |
| Prior chlamydia | |
| No | 88 (44.0) |
| Yes | 112 (56.0) |
| Hormonal contraception use | |
| No | 118 (59.0) |
| Yes | 82 (41.0) |
| Reported condom use | |
| No | 82 (41.0) |
| Yes | 118 (59.0) |
| Sexual partners prior 6 mo | |
| Median | 2 |
| Range | 0–10 |
| Concomitant gonorrhea | |
| No | 195 (97.5) |
| Yes | 5 (2.5) |
| Concomitant bacterial vaginosis | |
| No | 138 (69.0) |
| Yes | 62 (31.0) |
| Concomitant vaginal candidiasis | |
| No | 174 (87.0) |
| Yes | 26 (13.0) |
| Concomitant trichomoniasis | |
| No | 191 (95.5) |
| Yes | 9 (4.5) |
a One non–African American participant was Asian; the remaining were white.